The Clinical and Subjective Performance of Three Different MPDS With Silicon Hydrogel Lenses
This study is currently recruiting participants.
Verified August 2012 by Finnsusp Ltd.
Sponsor:
Finnsusp Ltd.
Information provided by (Responsible Party):
Finnsusp Ltd.
ClinicalTrials.gov Identifier:
NCT01665612
First received: August 8, 2012
Last updated: August 10, 2012
Last verified: August 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of the clinical investigation is to assess the clinical and subjective performance of three novel multipurpose disinfecting solutions (MPDS) in daily wear with two silicone hydrogel contact lenses (Lotrafilcon B and Comfilcon A).
| Condition | Intervention |
|---|---|
|
Adverse Reaction to Contact Lens Solution |
Device: Contact lens care solution |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Crossover Assignment Masking: Double Blind (Subject, Caregiver, Investigator) |
| Official Title: | The Evaluation of the Clinical and Subjective Performance of Three Different Contact Lens Care Solutions With Silicon Hydrogel Lenses |
Resource links provided by NLM:
Further study details as provided by Finnsusp Ltd.:
Primary Outcome Measures:
- Clinical performance [ Time Frame: 1 month ] [ Designated as safety issue: No ]TBUT, conjunctival and limbal hyperemia, corneal vascularization, epithelial and stromal oedema, corneal infiltrates, endothelial regularity, corneal staining and papillar conjunctivitis
Secondary Outcome Measures:
- Subjective performance [ Time Frame: 1 month ] [ Designated as safety issue: No ]E.g. Comfort
| Estimated Enrollment: | 40 |
| Study Start Date: | August 2012 |
| Estimated Primary Completion Date: | January 2013 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: MPDS1
Contact lens care solution
|
Device: Contact lens care solution
Comparison of clinical and subjective performation of the contact lens care solutions used with two types of contact lenses
|
|
Active Comparator: MPDS2
Contact lens care solution
|
Device: Contact lens care solution
Comparison of clinical and subjective performation of the contact lens care solutions used with two types of contact lenses
|
|
Active Comparator: MPDS3
Contact lens care solution
|
Device: Contact lens care solution
Comparison of clinical and subjective performation of the contact lens care solutions used with two types of contact lenses
|
Eligibility| Ages Eligible for Study: | 18 Years to 60 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
- age above 18
- experienced contact lens user
- good health (self-reported)
Exclusion Criteria:
- eye disease or eye operations
- pregnancy
- medication that can affect sight
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01665612
Contacts
| Contact: Riikka Järvinen, PhD | piilolinssitutkimus@gmail.com |
Locations
| Finland | |
| Raision Näkökulma | Recruiting |
| Raisio, Finland | |
| Contact: Maria Lilja, BSc piilolinssitutkimus@gmail.com | |
| Principal Investigator: Hanna Vaahtoranta-Lehtonen, Dr. | |
| Principal Investigator: Riikka Järvinen, PhD | |
| Principal Investigator: Jari Ahlgren, BSc.Optom. | |
Sponsors and Collaborators
Finnsusp Ltd.
Investigators
| Study Director: | Riikka Järvinen, PhD | University of Turku, Finland; Finnsusp Ltd, Finland |
| Principal Investigator: | Hanna Vaahtoranta-Lehtonen, Dr. Ophth. | Turku University Hospital, Finland |
More Information
No publications provided
| Responsible Party: | Finnsusp Ltd. |
| ClinicalTrials.gov Identifier: | NCT01665612 History of Changes |
| Other Study ID Numbers: | FI-2012 |
| Study First Received: | August 8, 2012 |
| Last Updated: | August 10, 2012 |
| Health Authority: | Finland: National supervisory authority for wellfare and health |
Keywords provided by Finnsusp Ltd.:
|
Contact lens Care solution MPDS comfort |
ClinicalTrials.gov processed this record on June 17, 2013